These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 565182)

  • 21. Pathogenesis of vaccine strains of measles virus in suckling hamsters.
    Mirchamsy H; Razavi J; Ahurai P
    Acta Virol; 1972 Jun; 16(1):77-9. PubMed ID: 4400679
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 23. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines.
    Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P
    Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The response to measles and distemper virus in immuno-suppressed and normal dogs.
    Slater EA
    J Am Vet Med Assoc; 1970 Jun; 156(12):1762-6. PubMed ID: 5422526
    [No Abstract]   [Full Text] [Related]  

  • 27. Exaggerated natural measles following attenuated virus immunization.
    St Geme JW; George BL; Bush BM
    Pediatrics; 1976 Jan; 57(1):148-9. PubMed ID: 1246490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A field trial of further attenuated live measles virus vaccines in Japan, 1968.
    Jpn J Med Sci Biol; 1969 Aug; 22(4):191-200. PubMed ID: 4982563
    [No Abstract]   [Full Text] [Related]  

  • 31. Heterogeneity with respect to s and T50 markers of various measles virus populations, variants of the Edmonston vaccine strain.
    Khozinsky VI; Seibil VB; Panteleyeva NS; Shapovalova SM
    Acta Virol; 1967 Nov; 11(6):506-10. PubMed ID: 4383885
    [No Abstract]   [Full Text] [Related]  

  • 32. [Optimizing cultural conditions of measles vaccine working seed lot with orthogonal experiments].
    Chen T; Chen P; Jia W; Liu Y; Jiang R; Peng W; Shi D
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):421-3. PubMed ID: 12910678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 34. Aseptic meningitis after vaccination against measles and mumps.
    Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M
    Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus.
    Willis MF; Warburton MF
    Med J Aust; 1974 May; 1(20):789-93. PubMed ID: 4853112
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and immunologic observation on 2 lines of attenuated measles vaccine virus on passage in chick embryo tissue culture].
    Chun H; Tsu TC; Tseng KH; Chang ST; Wu WH
    Zhonghua Yi Xue Za Zhi; 1973 Nov; 11():661-3. PubMed ID: 4203046
    [No Abstract]   [Full Text] [Related]  

  • 37. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A new combined vaccine against yellow fever and measles in infants aged 6 to 24 months in Mali].
    Soula G; Sylla A; Pichard E; Kodio B; Bentejac MC; Teulières L; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):885-97. PubMed ID: 1819436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles].
    Domorázková E; Janotová J; Vodicková M; Drevo M
    Cesk Pediatr; 1975 Oct; 30(10):468-70. PubMed ID: 1212713
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans.
    Etchart N; Hennino A; Friede M; Dahel K; Dupouy M; Goujon-Henry C; Nicolas JF; Kaiserlian D
    Vaccine; 2007 Sep; 25(39-40):6891-9. PubMed ID: 17764789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.